COMPUGEN LTD.

Patent Owner

Watch Compare Add to Portfolio

Stats

Details

Patent Activity in the Last 10 Years

Technologies

Intl Class Technology Matters Rank in Class
 
  
 
A61K PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES 32223
 
  
 
C07K PEPTIDES 31105
 
  
 
G01N INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES 9197
 
  
 
C07H SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS 891
 
  
 
C12N MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF 8159
 
  
 
A61N ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY 4103
 
  
 
C12P FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE 396
 
  
 
C12Q MEASURING OR TESTING PROCESSES INVOLVING ENZYMES OR MICRO-ORGANISMS 3122
 
  
 
A61P THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS 247
 
  
 
C12H PASTEURISATION, STERILISATION, PRESERVATION, PURIFICATION, CLARIFICATION, AGEING OF ALCOHOLIC BEVERAGES OR REMOVAL OF ALCOHOL THEREFROM 17

Top Patents (by citation)

Upgrade to the Professional Level to View Top Patents for this Owner. Learn More

Recent Publications

Publication # Title Filing Date Pub Date Intl Class
2017/0275,344 POLYPEPTIDES AND USES THEREOF AS A DRUG FOR TREATMENT OF AUTOIMMUNE DISORDERSAug 26, 15Sep 28, 17[A61K, C07K]
2017/0232,062 POLYPEPTIDES AND USES THEREOF AS A DRUG FOR TREATMENT OF MULTIPLE SCLEROSIS, RHEUMATOID ARTHRITIS AND OTHER AUTOIMMUNE DISORDERSApr 30, 16Aug 17, 17[A61K]
2017/0233,473 C10RF32 ANTIBODIES, AND USES THEREOF FOR TREATMENT OF CANCERFeb 28, 17Aug 17, 17[A61K, C07K]
2016/0272,707 VSTM5 ANTIBODIES, AND USES THEREOF FOR TREATMENT OF CANCER, INFECTIOUS DISEASES AND IMMUNE RELATED DISEASESSep 11, 14Sep 22, 16[A61K, C07K]

Recent Patents

Patent # Title Filing Date Issue Date Intl Class
9714289 Anti-PVRIG antibodies and methods of useSep 27, 16Jul 25, 17[A61K, C12N, G01N, C07K]
9617336 C10RF32 antibodies, and uses thereof for treatment of cancerJan 31, 13Apr 11, 17[A61K, G01N, A61N, C07K]
9555087 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsAug 26, 14Jan 31, 17[A61K, G01N, A61N, C07K]
9428574 Polypeptides and uses thereof for treatment of autoimmune disorders and infectionJul 01, 12Aug 30, 16[A61K, C07K]
9428586 Heparanase splice variantNov 30, 10Aug 30, 16[A61K, C12N, C07K]
9409987 Polypeptides and polynucleotides, and uses thereof for treatment of immune related disorders and cancerApr 16, 12Aug 09, 16[A61K, G01N, C07K]
9375466 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsMay 29, 13Jun 28, 16[A61K, G01N, A61N, C07K]
9347952 Soluble VEGFR-1 variants for diagnosis of preeclampsiaJan 12, 15May 24, 16[G01N, C07K]
9255132 Angiopoietin derived peptidesJun 18, 13Feb 09, 16[A61K, C07K]
9107862 Polypeptides and polynucleotides, and uses thereof as a drug target for producing drugs and biologicsFeb 15, 13Aug 18, 15[A61K, G01N, A61N, C07K]

View all patents..

Expired/Abandoned/Withdrawn Patents

Patent # Title Status Filing Date Issue/Pub Date Intl Class
2017/0037,141 POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICSAbandonedJan 30, 16Feb 09, 17[A61K, C07K]
2016/0216,281 SOLUBLE VEGFR-1 VARIANTS AND ASSAYS AND METHODS OF USE THEREOF FOR DIAGNOSISAbandonedApr 11, 16Jul 28, 16[G01N, C07K]
2016/0177,395 BIOMARKERS FOR THE PREDICTION OF RENAL INJURYAbandonedJan 07, 16Jun 23, 16[C12Q]
2016/0068,606 POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICSAbandonedJun 05, 15Mar 10, 16[A61K, C07K]
2015/0307,572 BIOACTIVE PEPTIDES AND METHODS OF USING SAMEAbandonedFeb 23, 15Oct 29, 15[C07K]
2015/0299,333 COMPOSITIONS AND METHODS FOR TREATMENT OF DRUG RESISTANT MULTIPLE MYELOMAAbandonedFeb 27, 15Oct 22, 15[A61K, C12N, G01N, C07K]
2015/0005,227 METHOD OF TREATING AN ISCHEMIA-REPERFUSION INJURY-RELATED DISORDER BY ADMINISTERING GPCR LIGANDSAbandonedSep 07, 14Jan 01, 15[A61K, C07K]
2014/0294,765 LSR ANTIBODIES, AND USES THEREOF FOR TREATMENT OF CANCERAbandonedJun 19, 13Oct 02, 14[A61K, G01N, C07K]
2014/0056,811 NEW CELL-PENETRATING PEPTIDES AND USES THEREOFAbandonedDec 26, 11Feb 27, 14[A61K]
2014/0037,549 GENETIC MARKERS FOR PROGNOSIS OF RHEUMATOID ARTHRITIS TREATMENT EFFICACYAbandonedFeb 12, 12Feb 06, 14[C12Q]
2013/0315,819 POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICSAbandonedMay 29, 13Nov 28, 13[A61K]
8575107 Clusterin derived peptideExpiredJan 22, 09Nov 05, 13[A61K, C07K]
2013/0209,463 POLYPEPTIDES AND USES THEREOF AS A DRUG FOR TREATMENT OF MULTIPLE SCLEROSIS, RHEUMATOID ARTHRITIS AND OTHER AUTOIMMUNE DISORDERSAbandonedJun 30, 11Aug 15, 13[C07K]
2011/0311,450 POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICSAbandonedDec 08, 09Dec 22, 11[A61K, C12N, G01N, A61P, C40B, C07K]
2011/0212,051 VARIANTS OF VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) RECEPTOR AND USE THEREOFAbandonedFeb 28, 11Sep 01, 11[A61K, C12N, G01N, A61P, C07K]
2011/0183,924 Methods and systems for annotating biomolecular sequencesAbandonedApr 23, 10Jul 28, 11[A61K, C07H, A61P, C07K]
2011/0052,501 POLYPEPTIDES AND POLYNUCLEOTIDES, AND USES THEREOF AS A DRUG TARGET FOR PRODUCING DRUGS AND BIOLOGICSAbandonedFeb 01, 09Mar 03, 11[A61K, C12N, G01N, A61P, C07K]
2011/0003,708 BIOMARKERS FOR THE PREDICTION OF RENAL INJURYAbandonedJun 25, 10Jan 06, 11[C07H, C12Q, G01N, C40B]
2010/0261,169 NOVEL NUCLEOTIDE AND AMINO ACID SEQUENCES, AND METHODS OF USE THEREOF FOR DIAGNOSISAbandonedDec 30, 07Oct 14, 10[C07H, C12Q, G01N, C07K]
2010/0248,270 Novel Nucleotide and Amino Acid Sequences, and Assays and Methods of Use Thereof for Diagnosis of Cardiac DiseaseAbandonedNov 23, 09Sep 30, 10[G01N, C07K]

View all patents..

Top Inventors for This Owner

Upgrade to the Professional Level to View Top Inventors for this Owner. Learn More

We are sorry but your current selection exceeds the maximum number of comparisons () for this membership level. Upgrade to our Level for up to -1 comparisons!

We are sorry but your current selection exceeds the maximum number of portfolios (0) for this membership level. Upgrade to our Level for up to -1 portfolios!.